+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Osteoarthritis Market and Competitive Landscape - 2020

  • ID: 5023487
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Osteoarthritis Market and Competitive Landscape - 2020, provides comprehensive insights into the Osteoarthritis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Osteoarthritis market size and drug sales. It also provides insights into Osteoarthritis epidemiology and late stage pipeline.

This research covers the following: Osteoarthritis treatment options, Osteoarthritis late stage clinical trials pipeline, Osteoarthritis prevalence by countries, Osteoarthritis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Osteoarthritis pipeline: Find out drugs in clinical trials for the treatment of Osteoarthritis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Osteoarthritis epidemiology: Find out the number of patients diagnosed (prevalence) with Osteoarthritis by countries
  • Osteoarthritis drugs: Identify key drugs marketed and prescribed for Osteoarthritis in the US, including trade name, molecule name, and company
  • Osteoarthritis drugs sales: Find out the sales value for Osteoarthritis drugs by countries
  • Osteoarthritis market valuations: Find out the market size for Osteoarthritis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Osteoarthritis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Osteoarthritis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Osteoarthritis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Osteoarthritis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Osteoarthritis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Osteoarthritis Treatment Options

2. Osteoarthritis Pipeline Insights
2.1. Osteoarthritis Phase 3 Clinical Trials
2.2. Osteoarthritis Phase 2 Clinical Trials
2.3. Osteoarthritis Phase 1 Clinical Trials

3. Osteoarthritis Epidemiology Analysis by Countries

4. US Osteoarthritis Market Insights
4.1. Marketed Drugs for Osteoarthritis in US
4.2. US Osteoarthritis Market Size & Forecast
4.3. US Osteoarthritis Drugs Sales & Forecast
4.4. US Osteoarthritis Market Share Analysis

5. Germany Osteoarthritis Market Insights
5.1. Marketed Drugs for Osteoarthritis in Germany
5.2. Germany Osteoarthritis Market Size & Forecast
5.3. Germany Osteoarthritis Drugs Sales Forecast
5.4. Germany Osteoarthritis Market Share Analysis

6. France Osteoarthritis Market Insights
6.1. Marketed Drugs for Osteoarthritis in France
6.2. France Osteoarthritis Market Size & Forecast
6.3. France Osteoarthritis Product Sales Forecast
6.4. France Osteoarthritis Market Share Analysis

7. Italy Osteoarthritis Market Insights
7.1. Marketed Drugs for Osteoarthritis in Italy
7.2. Italy Osteoarthritis Market Size & Forecast
7.3. Italy Osteoarthritis Product Sales Forecast
7.4. Italy Osteoarthritis Market Share Analysis

8. Spain Osteoarthritis Market Insights
8.1. Marketed Drugs for Osteoarthritis in Spain
8.2. Spain Osteoarthritis Market Size & Forecast
8.3. Spain Osteoarthritis Product Sales Forecast
8.4. Spain Osteoarthritis Market Share Analysis

9. UK Osteoarthritis Market Insights
9.1. Marketed Drugs for Osteoarthritis in UK
9.2. UK Osteoarthritis Market Size & Forecast
9.3. UK Osteoarthritis Product Sales Forecast
9.4. UK Osteoarthritis Market Share Analysis

10. Europe Osteoarthritis Market Insights
10.1. Europe Osteoarthritis Market Size & Forecast
10.2. Europe Osteoarthritis Product Sales Forecast
10.3. Europe Osteoarthritis Market Share Analysis

11. Japan Osteoarthritis Market Insights
11.1. Marketed Drugs for Osteoarthritis in Japan
11.2. Japan Osteoarthritis Market Size & Forecast
11.3. Japan Osteoarthritis Product Sales Forecast
11.4. Japan Osteoarthritis Market Share Analysis

12. Global Osteoarthritis Market Insights
12.1. Global Osteoarthritis Market Size & Forecast
12.2. Global Osteoarthritis Product Sales Forecast
12.3. Global Osteoarthritis Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Osteoarthritis Phase 3 Clinical Trials, Global, 2020
Table 2: Osteoarthritis Phase 2 Clinical Trials, Global, 2020
Table 3: Osteoarthritis Phase 1 Clinical Trials, Global, 2020
Table 4: Osteoarthritis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Osteoarthritis in US, 2019
Table 6: US Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 8: US Osteoarthritis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Osteoarthritis in Germany, 2019
Table 10: Germany Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 12: Germany Osteoarthritis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Osteoarthritis in France, 2019
Table 14: France Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 16: France Osteoarthritis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Osteoarthritis in Italy, 2019
Table 18: Italy Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 20: Italy Osteoarthritis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Osteoarthritis in Spain, 2019
Table 22: Spain Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 24: Spain Osteoarthritis Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Osteoarthritis in UK, 2019
Table 26: UK Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 28: UK Osteoarthritis Market Events and Trends, 2016 - 2024
Table 29: Europe Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Osteoarthritis in Japan, 2019
Table 32: Japan Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Osteoarthritis Product Sales ($mn), 2016 - 2024
Table 34: Japan Osteoarthritis Market Events and Trends, 2016 - 2024
Table 35: Global Osteoarthritis Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Osteoarthritis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Osteoarthritis Pipeline by Phase (%), Global, 2020
Figure 2: Osteoarthritis Prevalence by Countries, 2016 - 2024
Figure 3: US Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 4: US Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 5: US Osteoarthritis Market Share by Drugs (%), 2019
Figure 6: US Osteoarthritis Market - Future Market Share (%), 2024
Figure 7: Germany Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 8: Germany Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 9: Germany Osteoarthritis Market Share by Drugs (%), 2019
Figure 10: Germany Osteoarthritis Market - Future Market Share (%), 2024
Figure 11: France Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 12: France Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 13: France Osteoarthritis Market Share by Drugs (%), 2019
Figure 14: France Osteoarthritis Market - Future Market Share (%), 2024
Figure 15: Italy Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 16: Italy Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 17: Italy Osteoarthritis Market Share by Drugs (%), 2019
Figure 18: Italy Osteoarthritis Market - Future Market Share (%), 2024
Figure 19: Spain Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 20: Spain Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 21: Spain Osteoarthritis Market Share by Drugs (%), 2019
Figure 22: Spain Osteoarthritis Market - Future Market Share (%), 2024
Figure 23: UK Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 24: UK Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 25: UK Osteoarthritis Market Share by Drugs (%), 2019
Figure 26: UK Osteoarthritis Market - Future Market Share (%), 2024
Figure 27: Europe Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 28: Europe Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 29: Europe Osteoarthritis Market Share by Drugs (%), 2019
Figure 30: Europe Osteoarthritis Market - Future Market Share (%), 2024
Figure 31: Japan Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 32: Japan Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 33: Japan Osteoarthritis Market Share by Drugs (%), 2019
Figure 34: Japan Osteoarthritis Market - Future Market Share (%), 2024
Figure 35: Global Osteoarthritis Market Size ($mn), 2016 - 2024
Figure 36: Global Osteoarthritis Product Sales ($mn), 2016 - 2024
Figure 37: Global Osteoarthritis Market Share by Drugs (%), 2019
Figure 38: Global Osteoarthritis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll